ArticleNeuropsychiatric disease and treatment2026
Multimodal MRI Radiomics and Machine Learning Identify Node-Level Structural and Functional Alterations in HIV-Associated Asymptomatic Neurocognitive Impairment.
Article in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: In the era of combination antiretroviral therapy (cART), asymptomatic neurocognitive impairment (ANI) has become a common manifestation of HIV-associated neurocognitive disorders (HAND). Because ANI occurs without overt functional impairment, it may be overlooked in routine clinical practice despite being associated with an increased risk of subsequent symptomatic cognitive decline. This study aimed to develop a classification model for HIV-ANI by integrating node-level radiomic features derived from structural and functional MRI within a machine-learning framework, and to investigate the potential association between abnormalities in core cognitive network nodes and large-scale brain network dysfunction. Materials and Methods: A total of 67 individuals with HIV-associated asymptomatic neurocognitive impairment (HIV-ANI) and 70 cognitively intact individuals with HIV (HIV-IC) were included. Core regions of the default mode network (DMN), central executive network (CEN), and salience network (SN) were defined as regions of interest (ROIs). Node-level radiomic features were extracted from 3D T1-weighted imaging, amplitude of low-frequency fluctuation (ALFF), and regional homogeneity (ReHo) maps derived from resting-state fMRI. Unimodal, multimodal, and imaging-clinical fusion models were constructed using ElasticNet-regularized logistic regression after a stratified 7:3 training-test split. SHapley Additive exPlanations (SHAP) and a nomogram were used for model interpretation and individualized risk prediction. Results: The imaging-clinical fusion model achieved the highest AUC in the test set (0.735), with numerically better discriminative performance than the unimodal models. Functional features, particularly ReHo-derived features, contributed substantially to model prediction. SHAP analysis identified the medial prefrontal cortex, anterior and posterior cingulate cortices, and insula as key predictive regions. Clinical factors, including years of education and duration of HIV infection, also contributed to model performance. Conclusion: Structural and functional alterations are detectable within core cognitive network nodes at the HIV-ANI stage. The integration of multimodal MRI radiomic features with clinical factors showed potential for identifying HIV-ANI and provided preliminary evidence that node-level abnormalities may be associated with broader network dysfunction in early HAND. Further validation in larger, independent cohorts is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.